Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04443517 · ClinicalTrials.gov registry record · NA

EEG-Guided Analgesic Titration During General Anesthesia to Improve Early Neurocognitive Recovery in Older Patients

A NA study, sponsored by Columbia University.

Not yet
Registry status
NA
Development phase
600
Enrollment target

NCT04443517: Clinical Trial NA study, sponsored by Columbia University.

NCT04443517 is a NA study that has not yet begun recruiting, run by Columbia University. The registered enrollment target is 600 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04443517, a NA study, has not yet begun recruiting, sponsored by Columbia University.

NOT YET RECRUITING
Registry status
NA
Development phase
600 participants
Enrollment target

Study Summary

The investigators intend to recruit 600 participants to see if alpha power during anesthesia is influenced by analgesic medication and associated with a reduction of delirium following surgery.

Primary Outcome

The EEG data collected during the study duration will be processed using a customized script. Frontal alpha power (i.e., the cumulative power in the EEG alpha range) will be extracted from the EEGs and analyzed to compare the groups for the differences in the frontal alpha power.

Interventions

  • PROCEDURE Alpha Optimization
  • BEHAVIORAL Emergence from anesthesia with Dexmedetomidine

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2026-04-01
Est. Completion 2031-03-31
Phase NA
Columbia University

958 total trials

What is known before NCT04443517 opens enrollment

NCT04443517 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower).

The record links to 0 conditions, and to 2 interventions - of which Alpha Optimization is the first listed.

NCT04443517 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04443517 about?

NCT04443517 is a clinical study titled "EEG-Guided Analgesic Titration During General Anesthesia to Improve Early Neurocognitive Recovery in Older Patients". The investigators intend to recruit 600 participants to see if alpha power during anesthesia is influenced by analgesic medication and associated with a reduction of delirium following surgery.

What is the current status of trial NCT04443517?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2026-04-01. Estimated completion is 2031-03-31.

What interventions are being tested in trial NCT04443517?

The interventions under investigation include: Alpha Optimization (PROCEDURE), Emergence from anesthesia with Dexmedetomidine (BEHAVIORAL).

Who is sponsoring clinical trial NCT04443517?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04443517's enrollment target sits among peer trials

600 162nd of 2000 higher than 1,827 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00004317 · 600 participants · Phase 4

    Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

  • NCT00209235 · 600 participants · NA

    Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments

  • NCT01473784 · 600 participants · NA

    Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

  • NCT01866371 · 600 participants

    High Resolution Retinal Imaging

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04443517, the US trial registry maintained by the National Library of Medicine. NCT04443517 (mid enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.